ClinConnect ClinConnect Logo
Search / Trial NCT05365815

Melanated Group Midwifery Care (MGMC)

Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · May 3, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

ClinConnect Summary

The Melanated Group Midwifery Care (MGMC) study is exploring how a new approach to maternity care can help improve trust and engagement among Black women during their pregnancies. The goal is to see if this multi-level intervention can provide better support and care for Black birthing people, especially during a time that can be both exciting and stressful.

To participate, women must be pregnant, self-identify as Black, be under 20 weeks along, and be at least 15 years old. They should also be visiting the University of Chicago Medical Center for their first prenatal appointment and be able to speak and understand English. The study is currently recruiting participants, and it’s important to note that those with certain medical conditions requiring more specialized care or cognitive issues that affect understanding cannot join. If eligible, participants can expect to engage in a supportive environment designed to enhance their maternity care experience.

Gender

FEMALE

Eligibility criteria

  • Inclusion criteria for patients:
  • pregnant women who self-identify as Black on a standard prenatal intake form
  • less than 20 weeks pregnant
  • 15 years old or older
  • present to the general obstetrics group at the University of Chicago Medical Center for their new prenatal visit
  • speak and understand English
  • Inclusion criteria for providers:
  • • All black midwives, care coordinators, and community postpartum doulas at the University of Chicago are eligible to participate.
  • Exclusion criteria for patients:
  • having a condition for which they present to a higher level of obstetrics care (e.g., maternal fetal medicine) for their new prenatal visit
  • having a cognitive issue that impairs their ability to give informed consent.

About University Of Illinois At Chicago

The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.

Locations

Chicago, Illinois, United States

Patients applied

0 patients applied

Trial Officials

Stacie L Geller, PhD

Principal Investigator

University of Illinois Chicago

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials